Pilot Awards

The goal of the COBRE Center for Computational Biology of Human Disease (CBHD) Pilot Award Program is to identify and support activities of talented junior investigators working on human disease related questions that require computational analyses of complex data sets. Awardees gain access to the Computational Biology Core of staff data scientists who assist with data analysis. In addition, awardees may be considered for eventual recruitment to a Project Leader position in the COBRE CBHD program as existing Project Leaders attain their own independent funding and graduate from COBRE support.

The Center for Computational Biology of Human Disease awards two Pilot awards of $25,000 each year for 1-year projects. The call for proposal will appear on this page and on the home page of our website when it is released.

 

Active Pilot Awards

Congratulations to Chiung-Kuei Huang and George Lisi our third recipients of the COBRE CBHD Pilot Award Program!

 

Current

Chiung-Kuei Huang, PhD

TET1 in Cholangiocarcinoma Progression

Cholangiocarcinoma (CCA) is a devastating disease with a 5-year survival rate of 2%. The incidence of CCA has increased almost two-fold over the last three decades in the United States, and as such, there is an urgent need to find effective therapies for this lethal disease. Understanding the molecular pathogenesis of CCA development may lead to strategies for intervention and treatment. Recently, IDH1 and IDH2 mutations have been identified in about 20% of CCA patients.

George Lisi, PhD
George Lisi, PhD

Developing Experimental and Computational Synergy in Studies of Enzyme Allostery

Gene regulatory mechanisms are critical for proper cellular and protein function, and modern molecular biology techniques have linked numerous pathologies to dysregulation of genes. However, faithful modification of the genome in studies of pathogenic mutations and associated mechanisms have been difficult, rarely leading to effective treatments. The advent of CRISPR-Cas9 (Cas9) as an inexpensive tool for genome editing has created new possibilities for therapeutic gene targeting.

Completed

Lorin Crawford Head Shot
Lorin Crawford, PhD

Marginal Epistasis Tests for Dichotomous Traits Using Generalized Linear Models

Epistasis, commonly defined as the interaction between genetic loci, has long been hypothesized to play a key role in defining the genetic architecture underlying complex traits. However, despite the recent strong evidence of pervasive epistasis in many array- and sequence-based genome-wide association studies, statistical methods for powerfully mapping epistatic effects remain in their infancy. Existing epistatic mapping methods explicitly search over all pairwise or higher-order interactions when identifying significant nonlinear effects among genome-wide variants.

Iuliana Ene Head shot
Iuliana Ene, PhD

Defining the Roles of Perseverance and Heteroresistance in Persistent Fungal Infections

Candida species are a frequent and serious cause of bloodstream infections in the clinic.  Despite access to several antifungal drugs, systemic infections are associated with mortality rates that can exceed 40%.  In many patients, the organism persists in the bloodstream during antifungal treatment, despite the fact that recovered isolates are not drug resistant when tested in vitro.  The mechanisms responsible for such clinical persistence are unknown, but persistence is critically associated with therapeutic failure, recurrent infection and reduced survival.  Our preliminary studies indic

Peter Belenky head shot
Peter Belenky,PhD

Changes in Community Structure and Functional Responses of the Human Microbiome During Antibiotic Treatment in the Outpatient Setting

Current antibiotic therapy can lead to microbiome related complications and shifts in microbial populations that can contribute to the spread of antibiotic resistance. The work proposed here will transcriptionally profile the impacts of antibiotics on the composition and function of the oral microbiome in clinical samples. This functional information can identify therapies that more effectively utilize our current arsenal of antimicrobials in order to combat the impending antibiotic resistance crisis.

Ashley Webb, PhD

Genome-wide Interplay between the Pro-longevity FOXO Transcription Factors

Aging is a major risk factor for a number of diseases, including neurodegenerative diseases, diabetes, and cancer. However, the mechanisms responsible for aging remain poorly understood. Work from our lab and others has linked a particular family of proteins, known as FOXOs, to healthy aging in various species, including humans. The goal of this project is to understand how the different FOXO family members contribute to cellular maintenance in humans.